Panel discussion
Thermo Fisher Scientific
| Country: | United States |
| Website: | https://corporate.thermofisher.com |
| Room: | Sydney |
| Date: | 02.05.2022 |
| Time: | 17:30 – 18:15 |
Panel title
From Discovery through Development to Commercialization – Partnering to accelerate science
Panel summary
Biotech firms are critical innovators in development of the next great scientific invention, but we all know the process from discovery to commercialization is complex and, at times, challenging. In this panel led by Thermo Fisher Scientific, we explore the many stages of biotech customers’ journeys from funding to regulatory applications to clinical trials to large scale manufacturing and launch, and how to best leverage the expertise of partners to accelerate the process.
Speaker information
Moderation
Emilio Sanchez-Gomez, Vice President/General Manager, Lengnau site, Thermo Fisher Scientific
Panelists
- Katrin Rössger, Senior Biotech Account Manager, Thermo Fisher Scientific
- Massimiliano Borelli, Executive Account Director, Business Development, Thermo Fisher Scientific
- Matthias Saner, Senior Director, Instrument Sales, Thermo Fisher Scientific
Company profile
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or life-changing therapies, we are here to support them.
